Premier Anti-Aging Co., Ltd. (JP:4934)
:4934
4934 Stock Chart & Stats
¥702.00
-¥12.00(-1.43%)
At close: 4:00 PM EST
¥702.00
-¥12.00(-1.43%)
Day’s Range― - ―
52-Week Range¥593.00 - ¥979.00
Previous CloseN/A
Volume17.40K
Average Volume (3M)11.01K
Market Cap
¥5.28B
Enterprise Value¥1.38B
Total Cash (Recent Filing)¥4.66B
Total Debt (Recent Filing)¥1.11B
Price to Earnings (P/E)42.4
Beta1.03
Next Earnings
Jun 15, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)4.26
Shares Outstanding8,720,534
10 Day Avg. Volume8,960
30 Day Avg. Volume11,006
Financial Highlights & Ratios
PEG Ratio-0.12
Price to Book (P/B)1.14
Price to Sales (P/S)0.47
P/FCF Ratio5.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)49.3
Revenue Forecast (FY)¥15.00B
Bulls Say, Bears Say
Bulls Say
High Gross Profit Margin (76.65%)A 76.65% gross margin indicates structurally attractive unit economics and pricing power in its product mix. This large gross margin provides a durable cushion to absorb SG&A or sales volatility, supporting profitability and reinvestment even with uneven top-line trends.
Conservative Capital Structure (D/E 0.17)Very low leverage reduces refinancing and liquidity risk and preserves financial flexibility. A conservative capital structure supports sustained investment in R&D, marketing, or M&A and helps the company withstand demand shocks without compromising core operations.
Strong Free Cash Flow Conversion (FCF/Net Income 0.98)Nearly one-to-one conversion of net income to free cash flow signals high quality earnings and effective cash management. Reliable FCF supports capex, working capital needs and strategic initiatives while reducing dependence on external financing.
Bears Say
Declining Revenues (-7.23% Last Year)Sustained revenue decline undermines scale economics and limits the company's ability to leverage its high gross margins. Prolonged top-line contraction can strain marketing ROI, reduce bargaining power with suppliers, and constrain long-term growth investments.
Low Net Profit Margin (2.91%)A very low net margin despite high gross margin suggests elevated SG&A or structural cost inefficiencies. Low retained earnings reduce capacity to fund organic growth or innovation, increasing vulnerability to competitive pressure or margin compression.
Low Operating Margins (EBIT And EBITDA Are Low)Weak operating margins indicate limited operational leverage and potential inefficiencies in selling, R&D, or administrative functions. This restricts scalability and leaves less room to absorb rising input costs, hampering durable improvement in returns.
Premier Anti-Aging Co., Ltd. News
4934 FAQ
What was Premier Anti-Aging Co., Ltd.’s price range in the past 12 months?
Premier Anti-Aging Co., Ltd. lowest stock price was ¥593.00 and its highest was ¥979.00 in the past 12 months.
What is Premier Anti-Aging Co., Ltd.’s market cap?
Premier Anti-Aging Co., Ltd.’s market cap is ¥5.28B.
When is Premier Anti-Aging Co., Ltd.’s upcoming earnings report date?
Premier Anti-Aging Co., Ltd.’s upcoming earnings report date is Jun 15, 2026 which is in 76 days.
How were Premier Anti-Aging Co., Ltd.’s earnings last quarter?
Premier Anti-Aging Co., Ltd. released its earnings results on Mar 12, 2026. The company reported ¥4.26 earnings per share for the quarter, beating the consensus estimate of N/A by ¥4.26.
Is Premier Anti-Aging Co., Ltd. overvalued?
According to Wall Street analysts Premier Anti-Aging Co., Ltd.’s price is currently Overvalued.
Does Premier Anti-Aging Co., Ltd. pay dividends?
Premier Anti-Aging Co., Ltd. does not currently pay dividends.
What is Premier Anti-Aging Co., Ltd.’s EPS estimate?
Premier Anti-Aging Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Premier Anti-Aging Co., Ltd. have?
Premier Anti-Aging Co., Ltd. has 8,720,534 shares outstanding.
What happened to Premier Anti-Aging Co., Ltd.’s price movement after its last earnings report?
Premier Anti-Aging Co., Ltd. reported an EPS of ¥4.26 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 2.688%.
Which hedge fund is a major shareholder of Premier Anti-Aging Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4934
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Premier Anti-Aging Co., Ltd.
Premier Anti-Aging Co., Ltd. engages in the planning, development, import/export, mail order, wholesale, and retail business of cosmetics and health foods. The company offers its cosmetic products under the DUO and CANADEL brands. It is also involved on the information provision and consulting services related to anti-aging, beauty, and health; research on management and beauty of beauty clinics, etc.; and marketing research and collection and analysis of various information. The company was founded in 2009 and is headquartered in Tokyo, Japan.
Technical Analysis
Ivy Cosmetics Corporation
―
HABA Laboratories, Inc.
―
C'BON COSMETICS Co., Ltd.
―
I-ne CO., LTD.
―
AXXZIA, Inc.
―